Peanut Allergy Market Is Expected To Grow During The Forecast Period (2019-2032), DelveInsight | Key Players- Nestle Health Sciences, DBV Technologies, and Others

DelveInsight's Peanut Allergy Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Peanut Allergy Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Peanut Allergy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and the current forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Peanut Allergy: Overview
Food allergy is an abnormal response to a food triggered by the body's immune system. There are several types of immune responses to food. A peanut allergy is an allergic reaction to peanuts that occurs when the human body mistakenly identifies peanuts as harmful substances. Peanut allergy is recognized as one of the most severe food allergies due to its prevalence, persistency, and potential severity of the allergic reaction. Although other food allergies occurring in childhood usually resolve spontaneously with age, peanut sensitivity appears early in life and often persists indefinitely. Frequently, large quantities of peanut allergens are not needed to elicit an allergic reaction- even trace levels of peanut are capable of causing a hypersensitive reaction.

Download a sample copy of the market report @ https://www.delveinsight.com/sample-request/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Some of the key facts of the Peanut Allergy Market Report
• The prevalence has increased steadily over the past decade, mostly in the Western world. As per DelveInsight estimates, total prevalent population of Peanut Allergy in the 7MM was found to be 8,640,527 in 2017. The estimates show higher prevalence is in the US with 4,659,471 cases in 2017 and is a growing health problem in US, specifically in children.
• As per DelveInsight analysis, it is observed that, Japan has the least number of prevalent cases (1,548,318 for 2017) of Peanut Allergy, among the 7MM.
• The highest number of people affected with Peanut Allergy was found in the age-group of 65 and above years.
• Based on the severity, the diagnosed cases were divided in to mild, moderate to severe. The total cases of mild and moderate to severe Peanut Allergy in the US varied as 2,341,384 and 1,153,219 respectively.

Peanut Allergy Market

Peanut Allergy market size is anticipated to increase during the study period owing to the increasing incident population and rising awareness of Peanut Allergy in the 7MM. The expected launch of emerging therapies and the research and development activities of pharmaceutical companies will also fuel the market growth during the forecast period.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Peanut Allergy market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Peanut Allergy market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Peanut Allergy Market Outlook

Among 7MM, the United States accounts for the highest market size of Peanut Allergy in comparison with EU5 and Japan, for the study period (2017-2030). There was no standard of care for patients with Peanut Allergy, highlighting a pressing need to develop safe and effective curative interventions. The primary care of treatment, including antihistamines and injectable epinephrine, is prescribed to patients with mild, and moderate to severe cases of Peanut Allergy.

Request a Sample Report Now @ https://www.delveinsight.com/sample-request/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Peanut Allergy Epidemiology

The epidemiology section covers insights into the historical and current Peanut Allergy patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Peanut Allergy Drugs & Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peanut Allergy market or expected to get launched in the market during the study period. The analysis covers Peanut Allergy market uptake by drugs; patient uptake by therapies; and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Peanut Allergy Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Browse More Related Reports @ https://www.delveinsight.com/report-store/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Peanut Allergy Market Dynamics
The Peanut Allergy market dynamics is anticipated to change in the coming years owing to the expected launch of emerging therapies such as, DBV Technologies' Viaskin Peanut, AnaptysBio's ANB020 and Genentech's Omalizumab. The launch of various multiple-stage pipeline products will significantly revolutionize the Peanut allergy market dynamics in the near future. The emerging drug analysis along with their detailed profiling is done by the DelveInsight.

Peanut Allergy Market Size
The overall dynamics of the Peanut Allergy market is anticipated to change in the coming years owing to the expected launch of emerging therapies. DBV Technologies, AnaptysBio, Roche, Regeneron Pharmaceuticals, Prota Therapeutics, Camallergy, HAL Allergy B.V., and others are also developing treatments for Peanut allergies.

Peanut Allergy Companies
• Nestle Health Sciences
• DBV Technologies
• Regeneron/Sanofi
• Camallergy
• Vedanta Biosciences
• Alladapt Immunotherapeutics
• InnoUp Farma
• COUR Pharmaceuticals
• Novartis/Genentech, and Others

Peanut Allergy Drugs
• Palforzia (AR101)
• Viaskin Peanut
• Peanut hypoallergy vaccine, and Others

Read Full Research Report @ https://www.delveinsight.com/report-store/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Key Insights
2. Executive Summary
3. Competitive Intelligence Analysis
4. Market Overview at a Glance
5. Disease Background and Overview
6. Patient Journey
7. Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Peanut Allergy Treatment
11. Marketed Products
12. Emerging Therapies
13. Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Consult with our Business Expert @ https://www.delveinsight.com/report-store/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.